Add BrightSurf on Google Email

Cardiovascular events 1 year after RSV infection in adults

A cohort study of adults aged 45 or older with RSV infection found a significant excess risk of cardiovascular events over 1 year, comparable in magnitude to influenza infection. This highlights the importance of RSV as a potential risk factor for cardiovascular morbidity and underscores the need for vaccination to mitigate this burden.

SourceJAMA Network·JournalJAMA Network Open·DateDec 8, 2025

Americans more likely to accept guidance from AMA than CDC on vaccine safety

A survey of adults in the US found that most people prefer the American Medical Association's (AMA) guidance on vaccine safety over the Centers for Disease Control and Prevention's (CDC), citing concerns about the CDC's recent changes to its website. According to the survey, 35% of Americans would accept the AMA's recommendation, while...

‘Mental model’ approach shows promise in reducing susceptibility to misconceptions about mRNA vaccination

Researchers tested a 'mental model' approach to counter unwarranted fears about mRNA technology. The study found that exposing people to visual models of how vaccines work and/or how cells protect DNA from foreign fragments undercuts the effect of exposure to misconceptions.

SourceAnnenberg Public Policy Center of the University of Pennsylvania·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateNov 24, 2025

New research confirms HPV vaccination prevents cervical cancer

Two new Cochrane reviews show that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus. Girls vaccinated before the age of 16 were found to be 80% less likely to develop cervical cancer.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateNov 23, 2025

Predicting disease outbreaks using social media

A new approach developed by University of Waterloo researchers uses social media posts to identify early warning signs of increasing vaccine skepticism. This method can detect patterns in data much more effectively than traditional methods, providing a bigger lead time before an outbreak occurs.

SourceUniversity of Waterloo·JournalMathematical Biosciences and Engineering·DateNov 18, 2025

Measles immunity 90% in BC’s Lower Mainland

A recent study found that 90% of people in BC's Lower Mainland have detectable antibodies against measles, indicating high vaccine coverage and population protection. However, the study also found lower immunity rates among older adults, with only 75% of those aged 20-39 having measurable antibodies.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeObservational study·DateOct 14, 2025

National Association of School Nurses reaffirms strong support for school immunization requirements

The National Association of School Nurses reaffirms its commitment to school immunization requirements, citing the life-saving role of vaccines. The updated position statement recommends eliminating vaccine exemptions except in medical contraindications, emphasizing the importance of timely and complete vaccinations.

SourceSAGE·JournalThe Journal of School Nursing·TypeCommentary/editorial·DateOct 10, 2025

Drop in childhood vaccination coverage: Dutch study identifies trends driven by socioeconomic factors

A Dutch study found that vaccination coverage among children declined faster in households with lower income and those not attending daycare. The study, which analyzed over 2 million children, identified sociodemographic factors contributing to the decline, including parental education and migration background.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeData/statistical analysis·DateOct 9, 2025

Protecting the protectors: as measles cases surge, how can we help healthcare workers get vaccinated?

A study explores barriers to measles vaccination among female healthcare workers in a London hospital. The findings highlight low knowledge of measles and its complications, as well as concerns about the vaccine's link to autism. The article argues that ensuring healthcare workers are aware of their vaccination status, providing better...

SourceFrontiers·JournalFrontiers in Public Health·TypeSurvey·DateSep 26, 2025

Most Americans favor MMR vaccine requirement for public school, Annenberg survey finds

A recent Annenberg Public Policy Center survey found that 70% of the public supports vaccine requirements for MMR in schools. The percentage increased from 63% in August 2023. The survey also showed that over 7 in 10 U.S. adults support a policy making it mandatory for parents to vaccinate their children against preventable diseases.

How nations balanced health and economy in the COVID-19 pandemic: A global review

Researchers analyzed multiple countries' performance in achieving infection control and economic recovery, highlighting the impact of risk attitudes, patience, and trust on policy decisions. Countries with high levels of trust and patience managed to limit deaths and resuming production, while those with low trust and higher risk toler...

SourceShinshu University·JournalJournal of Policy Modeling·TypeData/statistical analysis·DateSep 11, 2025

Broad COVID-19 vaccination makes economic sense, especially for older adults, study finds

A new study by Michigan Medicine University of Michigan researchers concludes that broad COVID-19 vaccination in adults saves the US more money than it spends, with significant economic benefits for those over 65 and middle-aged adults. The model focuses on preventing deaths, hospitalizations, and lost productivity.

SourceMichigan Medicine - University of Michigan·JournalJAMA Network Open·TypeData/statistical analysis·DateAug 13, 2025

Safety of JN.1-updated mRNA COVID-19 vaccines

A nationwide cohort study of 1 million adults found no increased risk of 29 adverse events after vaccination with the updated COVID-19 mRNA vaccine containing the SARS-CoV-2 Omicron JN.1 lineage. The study provides reassuring safety data on the new vaccine, which has been widely adopted in response to the Omicron variant

SourceJAMA Network·JournalJAMA Network Open·DateJul 28, 2025